• Passa al contenuto principale
BC

biochimica clinica

it_IT Italian
it_IT Italian en_US English
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

CONTRIBUTI SCIENTIFICI – Scientific Papers

Volume:

Biochimica Clinica 2012; 36(5) 349-357

Pubblicato on-line:

DOI:

Scarica in PDF:
Autenticazione richiesta

Screening della malattia celiaca nei donatori di sangue della provincia di Bergamo: dati preliminari su 18.498 soggetti

AUTORI

Federica Zunino1, Maria Grazia Alessio1, Barbara Giussani2, Silva Grigio2, Antonella Giudici2, Maria del Carmen Baigorria Vaca1, Giovanna Azzarà1, Tiziana Benedetti1, Carmela Brascia1, Giovanna Lazzari1, Caterina Maestroni1, Ferdinanda Noris1, Maurizio Parimbelli1, Giulia Previtali1, Davide Barachetti1, Carlo Catassi3
1Dipartimento di Medicina di Laboratorio, Ospedali Riuniti di Bergamo
2AVIS Provinciale Bergamo
3Università Politecnica delle Marche, Ancona

ABSTRACT

Screening of the celiac disease (CD) among blood donors in the Bergamo province: preliminary data on 18.498 subjects.

CD is a common cause of hypoferritinemia and anemia. A high percentage of blood donors from the Bergamo district stopped blood donation because of an iron deficiency. The aim of this study was to determine the prevalence of CD in this population. From May 2010 to December 2011, 18,498 donors underwent serological
screening with measurement of human anti-recombinant transglutaminase (tTG) IgA and synthetic anti-deamidated gliadin antibodies (AGA DGP) IgG. 440 donors (2.3%) resulted positive either to one or both screening tests. 363 donors showed an isolated positivity for AGA DGP IgG (n=309) or anti-tTG IgA (n=54) and are now following up. 76
(0.4%) were positive for anti-tTG IgA, subsequently confirmed by anti-endomysial antibodies (EMA). A donor was positive for AGA DGP IgG and anti-tTG IgG: the determination of total IgA confirmed the presence of an absolute deficit of IgA. 58 people performed the duodenal biopsy: 95% showed damage to the duodenal mucosa and got a diagnosis of CD. The estimated prevalence of CD was 􀀀1:250. Only 10% of individuals were totally asymptomatic; signs and/or symptoms related to CD were often present at the moment of the diagnosis. Our results suggest the need for screening for CD at the time of blood donor enrollment.

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967